Get started
Author

M. Moschioni

Observed names: Monica Moschioni, Moschioni, Monica
ORCID: 0009-0003-9345-3630
Observed ORCID: 0009-0003-9345-3630
OpenAlex ID: A5013573935
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
2021 · L. Guglielmetti, E. Ardizzoni, et al. · Trials · 35
PDF
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
2023 · S. B. Patil, M. Tamirat, et al. · Trials · 18
PDF
mRNA vaccines and therapeutics beyond COVID-19: A review of the global clinical development landscape, low- and middle-income countries involvement and relevance to their contexts
2026 · Monica Moschioni, Rafay Anwer Siraji, et al. · Human Vaccines & Immunotherapeutics · 6
mRNA vaccines and therapeutics beyond COVID-19: A review of the global clinical development landscape, low- and middle-income countries involvement and relevance to their contexts
2026 · Moschioni, Monica, Siraji, Rafay Anwer, et al. · Figshare
Works count: 5
Citation count: 59
H-index: 3
I10-index: 2
Year
Topic
Type